The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies

BACKGROUND: The private versus public contribution to developing new health knowledge and interventions is deeply contentious. Proponents of commercial innovation highlight its role in late-stage clinical trials, regulatory approval, and widespread distribution. Proponents of public innovation point...

Descripción completa

Detalles Bibliográficos
Autores principales: Beall, Reed F., Moradpour, Javad, Hollis, Aidan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535173/
https://www.ncbi.nlm.nih.gov/pubmed/34679120
http://dx.doi.org/10.1371/journal.pone.0258013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535173/
https://www.ncbi.nlm.nih.gov/pubmed/34679120
http://dx.doi.org/10.1371/journal.pone.0258013

Ejemplares similares